Akriti Jain, MD, is from the Department of Hematology and Medical Oncology, at the Cleveland Clinic.
Impact of Non-ABL1 Mutations on Outcomes in Chronic Myeloid Leukemia
Akriti Jain, MD, discusses her presentation from the 2024 American Society of Hematology Meeting and Exposition.
Exciting Advances in AML Treatment: Jain on Key Highlights for ASH 2024
Akriti Jain, MD, discusses what she is most looking forward to seeing presented at the upcoming 2024 American Society of Hematology Annual Meeting and Exposition.